Avadel pharmaceuticals to present at the jefferies biotech cns/neuro summit

Dublin, ireland, oct. 05, 2023 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the jefferies biotech cns/neuro summit on thursday, october 12 at 9:00 a.m. et.
AVDL Ratings Summary
AVDL Quant Ranking